30. A firm’s enterprise and equity values will increase in response to all of the following variables assuming
other things are equal except for
a. An increase in profitable revenue growth
b. A reduction in cost of sales as a percent of sales
c. An increase in the firm’s weighted average cost of capital
d. A decrease in the firm’s weighted average cost of capital
e. A decrease in SG&A as a percent of sales
Short Essay Examination Questions
M&A FINANCIAL MODEL APPLICATIONS
KEY POINTS: M&A models
• Address valuation, deal structuring, and financing questions;
• May be used by both buyers and sellers to assess alternative deal structures; and
• Help define risks associated with specific options in “real time.”
___________________________________________________________________________
In a deal fraught with tax and competitive risks, Shire PLC announced on January 11, 2016 that it had inked a deal
valued at about $32 billion to acquire Baxalta Inc., ending its six month pursuit of the firm. The pair had reached an
agreement earlier but had difficulty overcoming fears that the combination would run afoul of U.S. laws precluding
firms created as a result of a tax-free spinoff from acquiring another firm in the two year period following the
spinoff. As such, the deal could have created a substantial tax liability for Shire’s former parent, Baxter
International which had spun off Shire in July 2015. An additional risk in buying Baxalta was the intensifying
competition to its primary cash generating hemophilia drug from a promising series of similar treatments being
developed by rivals.
Shire PLC is an Irish-headquartered specialty pharmaceutical firm with global operations in more than 100
countries. Originating in the United Kingdom, the firm has substantial operations in the United States. Following the
withdrawal of American based pharmaceutical firm AbbVie’s bid to acquire Shire due to concerns about new tax
inversion rules, Shire’s stock plummeted almost 30%. To support its share price, Shire announced its intention to
acquire a string of smaller firms with proven treatments for rare diseases.
What would be the likely impact of such a strategy? Sophisticated firms typically utilize long range planning as
described in Chapters 4 and 5 to evaluate their ability to perform in what they perceive as their future competitive
environment. Financial models are commonly used to project a “baseline” forecast or reference point of cash flow
over a number of years to determine if the firm’s current strategy results in achieving its vision and long-term goals.
In addition to their role in the firm’s business planning process, financial models play a critical role in the
decision-making process underlying M&As. Shire initiated its largest takeover attempt in August 2015 when it made
an unsolicited offer to Acquire Baxalta for about $30 billion in an all–stock bid. Although the proposal included a
nearly 30% premium, Baxalta’s board rejected the offer claiming that it undervalued the firm and insisted that any
bid should contain a substantial amount of cash.